Chinese researchers have succeeded in identifying a potential drug to treat liver carcinoma.
In a study, published in the World Journal of Gastroenterology, a research team led by Dr. Jian-Guo Cao investigate the anti-tumour effect of a derivative of the natural flavonoid Chrysin, known as 5-allyl-7-gen-difluoromethylenechrysin (ADFMChR).
Liver Cancer - Types, Causes, Symptoms, Diagnosis, Treatment, Prevention, Progosis
Liver or hepatic cancer is an abnormal growth of cells in the liver. The leading cause of the disease is cirrhosis or scarring of the liver tissue.
Liver or hepatic cancer is an abnormal growth of cells in the liver. The leading cause of the disease is cirrhosis or scarring of the liver tissue.
The apoptosis of HepG2 cells was determined by flow cytometry using propidium iodide fluorescence staining.
The research team found that ADFMChR significantly inhibited the proliferation of HepG2 cells in a dose-dependent manner, with little effect on growth of L-02 cells.
Hypothyroidic Women At Higher Risk of Liver Cancer
Women who have a history of hypothyroidism may be at an increased risk of developing liver cancer, according to a study.
Women who have a history of hypothyroidism may be at an increased risk of developing liver cancer, according to a study.
Source-ANI
TAN
Statin Use Associated With Reduction In Liver Cancer Risk And Lowers Need For Gallbladder Removals
Statin drugs, which are commonly used by people for reducing their cholesterol and risk of heart disease, may prevent liver cancer and lead to a reduction in the need for gallbladder removals.
Statin drugs, which are commonly used by people for reducing their cholesterol and risk of heart disease, may prevent liver cancer and lead to a reduction in the need for gallbladder removals.
New Link in Liver Cancer
Liver damage can be triggered by various insults, including hepatitis infection or alcohol-induced cirrhosis.
Liver damage can be triggered by various insults, including hepatitis infection or alcohol-induced cirrhosis.
